Nicotine and Perphenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicotine (nicotine) and Perphenazine (perphenazine). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Nicotine and Perphenazine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nicotine?

Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 20,443 Nicotine users. Check the latest studies of Nicotine.

What is Perphenazine?

Perphenazine has active ingredients of perphenazine. It is often used in bipolar i disorder. eHealthMe is studying from 2,712 Perphenazine users. Check the latest studies of Perphenazine.



On Jul, 18, 2026

13 people who take Nicotine and Perphenazine together, and have interactions are studied.

Nicotine and Perphenazine drug interactions.

What are the common drug interactions of Nicotine and Perphenazine, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Death
  5. Intestinal resection
  6. Suicidal ideation
  7. Therapeutic response decreased (less preventive response)

male:

  1. Chronic kidney disease
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Insomnia (sleeplessness)
  5. Nicotine dependence
  6. Obesity (having too much body fat)
  7. Pancreatitis (inflammation of pancreas)
  8. Psychomotor hyperactivity (feelings of extreme restlessness)
  9. Weight decreased
  10. Weight increased

What are the common drug interactions of Nicotine and Perphenazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Agitation (state of anxiety or nervous excitement)
  2. Drug dependence
  3. Euphoric mood (excessively happy but may become angry or irritable)
  4. Insomnia (sleeplessness)
  5. Nicotine dependence
  6. Pancreatitis (inflammation of pancreas)
  7. Psychomotor hyperactivity (feelings of extreme restlessness)

20-29:

  1. Neutropenia (an abnormally low number of neutrophils)

30-39:

  1. Granulocytopenia (lack of granulocyte)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Obesity (having too much body fat)
  2. Weight decreased
  3. Weight increased
  4. Blood cholesterol increased
  5. Blood glucose increased
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Erectile dysfunction
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)

60+:

  1. Application site irritation
  2. Chronic kidney disease
  3. Myalgia (muscle pain)
  4. Overdose
  5. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
  2. High Blood Pressure: 3 people, 23.08%
  3. Stress And Anxiety: 3 people, 23.08%
  4. Depression: 3 people, 23.08%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 15.38%
  6. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 15.38%
  7. Diabetes: 2 people, 15.38%
  8. Prostatomegaly (enlargement of the prostate): 2 people, 15.38%
  9. Pain: 2 people, 15.38%
  10. Inflammation: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Nicotine and Perphenazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nicotine and Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nicotine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicotine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perphenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nicotine and perphenazine (the active ingredients of Nicotine and Perphenazine, respectively), and Nicotine and Perphenazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: